Ranking Healthcare Stocks YTD 2009

November 23, 2009 · By namshik

(13)

Loading ...

Ranking | Company (Ticker) | Year-to-Date Performance

1 HeartWare International, Inc. (NASDAQ:HTWR) 8721.6%
2 Vasogen Inc. (USA) (NASDAQ:IPCI) 2344.3%
3 Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) 1956.0%
4 Human Genome Sciences (NASDAQ:HGSI) 1191.5%
5 Opexa Therapeutics Inc. (NASDAQ:OPXA) 979.0%

6 OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI) 977.3%
7 Speedus Corp. (NASDAQ:SPDE) 969.5%
8 Keryx Biopharmaceuticals (NASDAQ:KERX) 944.0%
9 Cell Therapeutics, Inc. (NASDAQ:CTIC) 671.4%
10 NeurogesX, Inc (NASDAQ:NGSX) 622.2%
11 BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) 597.1%
12 Compugen Ltd. (USA) (NASDAQ:CGEN) 553.5%
13 EntreMed, Inc. (NASDAQ:ENMD) 535.8%
14 Targacept , Inc. (NASDAQ:TRGT) 526.4%
15 ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) 520.7%
16 Dendreon Corporation (NASDAQ:DNDN) 511.6%
17 Oncothyreon Inc. (NASDAQ:ONTY) 490.5%
18 Candela Corporation (NASDAQ:CLZR) 489.8%
19 ISTA Pharmaceuticals, Inc. (NASDAQ:ISTA) 481.9%
20 Sinovac Biotech Ltd. (NASDAQ:SVA) 447.1%
21 Protalix BioTherapeutics Inc. (AMEX:PLX) 444.0%
22 Alpha Pro Tech, Ltd. (AMEX:APT) 425.3%
23 Angiotech Pharmaceuticals, Inc. (USA) (NASDAQ:ANPI) 400.0%
24 Medifast, Inc. (NYSE:MED) 383.5%
25 Tenet Healthcare Corporation (NYSE:THC) 358.3%
26 CEL-SCI Corporation (AMEX:CVM) 356.1%
27 EXACT Sciences Corporation (NASDAQ:EXAS) 356.1%
28 AVANIR Pharmaceuticals (NASDAQ:AVNR) 341.3%
29 Interleukin Genetics, Inc (AMEX:ILI) 340.0%
30 IsoRay, Inc. (AMEX:ISR) 340.0%
31 pSivida Corp. (NASDAQ:PSDV) 335.1%
32 Delcath Systems, Inc. (NASDAQ:DCTH) 310.9%
33 MediciNova, Inc. (NASDAQ:MNOV) 308.8%
34 Helicos BioSciences Corp. (NASDAQ:HLCS) 307.7%
35 BioForm Medical, Inc. (NASDAQ:BFRM) 289.0%
36 Digirad Corporation (NASDAQ:DRAD) 282.8%
37 CytRx Corporation (NASDAQ:CYTR) 280.0%
38 Inhibitex, Inc. (NASDAQ:INHX) 278.1%
39 Hooper Holmes, Inc. (AMEX:HH) 272.0%
40 Neostem Inc. (AMEX:NBS) 266.0%
41 PositiveID Corporation (NASDAQ:PSID) 264.9%
42 Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ) 264.3%
43 Aspect Medical Systems, Inc. (NASDAQ:ASPM) 259.8%
44 SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) 259.5%
45 Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) 256.1%
46 Endologix, Inc. (NASDAQ:ELGX) 254.2%
47 Health Management Associates, Inc. (NYSE:HMA) 252.5%
48 Hi-Tech Pharmacal Co. (NASDAQ:HITK) 252.4%
49 Gentium S.p.A. (ADR) (NASDAQ:GENT) 249.2%
50 MedQuist Inc. (NASDAQ:MEDQ) 245.4%
51 BioScrip Inc. (NASDAQ:BIOS) 244.1%
52 IRIDEX Corporation (NASDAQ:IRIX) 228.2%
53 YM BioSciences Inc. (USA) (AMEX:YMI) 227.2%
54 Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) 218.1%
55 Palatin Technologies, Inc. (AMEX:PTN) 211.5%
56 Antares Pharma, Inc. (AMEX:AIS) 208.1%
57 Adeona Pharmaceuticals, Inc. (AMEX:AEN) 207.3%
58 Health Fitness Corporation (AMEX:FIT) 206.9%
59 HearUSA, Inc. (AMEX:EAR) 205.7%
60 Curis, Inc. (NASDAQ:CRIS) 201.3%
61 Trubion Pharmaceuticals, Inc. (NASDAQ:TRBN) 200.8%
62 American Shared Hospital Services (AMEX:AMS) 195.2%
63 Inovio Biomedical Corp. (AMEX:INO) 194.3%
64 Electro-Optical Sciences, Inc. (NASDAQ:MELA) 190.8%
65 NeuroMetrix, Inc. (NASDAQ:NURO) 188.5%
66 Fonar Corporation (NASDAQ:FONR) 188.0%
67 Brookdale Senior Living, Inc. (NYSE:BKD) 186.7%
68 Bruker Corporation (NASDAQ:BRKR) 185.9%
69 Cerus Corporation (NASDAQ:CERS) 185.7%
70 Hemispherx BioPharma, Inc (AMEX:HEB) 183.3%
71 Sirona Dental Systems, Inc. (NASDAQ:SIRO) 182.5%
72 Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) 182.4%
73 SeraCare Life Sciences, Inc. (NASDAQ:SRLS) 181.4%
74 Caliper Life Sciences Inc. (NASDAQ:CALP) 178.4%
75 Pluristem Therapeutics Inc. (NASDAQ:PSTI) 178.1%
76 China Pharma Holdings, Inc. (AMEX:CPHI) 172.8%
77 NBTY, Inc. (NYSE:NTY) 167.4%
78 Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) 165.1%
79 Anika Therapeutics, Inc. (NASDAQ:ANIK) 164.1%
80 AtriCure Inc. (NASDAQ:ATRC) 163.7%
81 DexCom, Inc. (NASDAQ:DXCM) 163.4%
82 I-Flow Corporation (NASDAQ:IFLO) 163.3%
83 Tianyin Pharmaceutical Co, Inc. (AMEX:TPI) 162.3%
84 Allied Healthcare International Inc. (NASDAQ:AHCI) 155.1%
85 Santarus, Inc. (NASDAQ:SNTS) 154.8%
86 Trinity Biotech plc (ADR) (NASDAQ:TRIB) 154.4%
87 Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) 154.1%
88 Cytomedix, Inc. (AMEX:GTF) 152.6%
89 WellCare Health Plans, Inc. (NYSE:WCG) 152.5%
90 AdCare Health Systems, Inc. (AMEX:ADK) 145.3%
91 Dr. Reddy’s Laboratories Limited (ADR) (NYSE:RDY) 145.1%
92 Trimeris, Inc. (NASDAQ:TRMS) 144.8%
93 Misonix, Inc. (NASDAQ:MSON) 143.6%
94 NxStage Medical, Inc. (NASDAQ:NXTM) 143.5%
95 Skystar Bio-Pharmaceutical Company (NASDAQ:SKBID) 142.1%
96 MDRNA, Inc. (NASDAQ:MRNA) 141.2%
97 Tiens Biotech Group (USA), Inc. (AMEX:TBV) 140.8%
98 ImmuCell Corporation (NASDAQ:ICCC) 139.1%
99 Savient Pharmaceuticals, Inc. (NASDAQ:SVNT) 138.5%
100 CardioDynamics Int’l Corp (NASDAQ:CDIC) 137.2%
101 Dynatronics Corporation (NASDAQ:DYNT) 134.6%
102 Orchid Cellmark, Inc. (NASDAQ:ORCH) 134.3%
103 Pharmacyclics, Inc. (NASDAQ:PCYC) 132.9%
104 The Spectranetics Corporation (NASDAQ:SPNC) 130.3%
105 EDAP TMS S.A. (ADR) (NASDAQ:EDAP) 128.5%
106 Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY) 123.1%
107 Advocat Inc. (NASDAQ:AVCA) 122.8%
108 Athersys, Inc. (NASDAQ:ATHX) 122.2%
109 AVI BioPharma, Inc. (NASDAQ:AVII) 121.9%
110 SIGA Technologies, Inc. (NASDAQ:SIGA) 120.2%
111 Inverness Medical Innovations, Inc. (NYSE:IMA) 120.0%
112 A.P. Pharma, Inc. (NASDAQ:APPA) 117.9%
113 Cornerstone Therapeutics, Inc. (NASDAQ:CRTX) 117.7%
114 Vical Incorporated (NASDAQ:VICL) 117.7%
115 Intuitive Surgical, Inc. (NASDAQ:ISRG) 117.7%
116 VirtualScopics, Inc. (NASDAQ:VSCP) 113.9%
117 Invitrogen Corporation (NASDAQ:LIFE) 112.3%
118 SunLink Health Systems, Inc. (AMEX:SSY) 112.0%
119 Air Methods Corporation (NASDAQ:AIRM) 111.7%
120 LeMaitre Vascular, Inc. (NASDAQ:LMAT) 111.4%
121 Community Health Systems (NYSE:CYH) 111.1%
122 Immunomedics, Inc. (NASDAQ:IMMU) 108.8%
123 ev3 Inc. (NASDAQ:EVVV) 106.6%
124 IGI Laboratories, Inc. (AMEX:IG) 106.2%
125 Telik, Inc. (NASDAQ:TELK) 105.3%
126 GenVec, Inc. (NASDAQ:GNVC) 104.6%
127 Given Imaging Ltd. (NASDAQ:GIVN) 104.4%
128 Five Star Quality Care, Inc. (AMEX:FVE) 103.9%
129 Peregrine Pharmaceuticals (NASDAQ:PPHM) 103.5%
130 AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) 102.0%
131 Corcept Therapeutics Incorporated (NASDAQ:CORT) 102.0%
132 Affymax, Inc. (NASDAQ:AFFY) 100.9%
133 MannKind Corporation (NASDAQ:MNKD) 100.6%
134 Medivation, Inc. (NASDAQ:MDVN) 100.6%
135 VIA Pharmaceuticals, Inc. (NASDAQ:VIAP) 100.1%
136 Bionovo Inc. (NASDAQ:BNVI) 100.0%
137 DepoMed, Inc. (NASDAQ:DEPO) 100.0%
138 Incyte Corporation (NASDAQ:INCY) 99.2%
139 Retractable Technologies, Inc. (AMEX:RVP) 97.9%
140 ZymoGenetics, Inc. (NASDAQ:ZGEN) 97.3%
141 NMT Medical, Inc. (NASDAQ:NMTI) 95.8%
142 Herbalife Ltd. (NYSE:HLF) 95.6%
143 ImmunoGen, Inc. (NASDAQ:IMGN) 94.6%
144 Orthofix International NV (NASDAQ:OFIX) 94.2%
145 CYANOTECH CORP (NASDAQ:CYAN) 93.8%
146 SenoRx, Inc. (NASDAQ:SENO) 93.6%
147 Sunrise Senior Living, Inc. (NYSE:SRZ) 92.3%
148 Transition Therapeutics Inc. (NASDAQ:TTHI) 92.3%
149 NUCRYST Pharmaceuticals Corp. (USA) (NASDAQ:NCST) 92.2%
150 NovaBay Pharmaceuticals, Inc. (AMEX:NBY) 92.2%
151 The Cooper Companies, Inc. (NYSE:COO) 91.8%
152 American Medical Systems Holdings, Inc. (NASDAQ:AMMD) 90.9%
153 Flamel Technologies S.A. (ADR) (NASDAQ:FLML) 90.8%
154 Cyclacel Pharmaceuticals Inc. (NASDAQ:CYCC) 90.5%
155 Amarin Corporation plc (ADR) (NASDAQ:AMRN) 90.1%
156 OXiGENE, Inc. (NASDAQ:OXGN) 89.4%
157 IPC The Hospitalist Company, Inc. (NASDAQ:IPCM) 89.3%
158 Commonwealth Biotechnologies, Inc. (NASDAQ:CBTE) 88.4%
159 Prospect Medical Holdings Inc (NASDAQ:PZZ) 88.4%
160 WuXi PharmaTech (Cayman) Inc. (ADR) (NYSE:WX) 88.2%
161 Antigenics, Inc. (NASDAQ:AGEN) 87.5%
162 China Shenghuo Pharmaceutical Hldg, Inc. (AMEX:KUN) 87.5%
163 Rosetta Genomics Ltd. (USA) (NASDAQ:ROSG) 87.0%
164 Avigen, Inc. (NASDAQ:AVGN) 86.8%
165 Chindex International, Inc. (NASDAQ:CHDX) 81.5%
166 Arrhythmia Research Technology, Inc. (AMEX:HRT) 81.3%
167 Osteotech, Inc. (NASDAQ:OSTE) 79.9%
168 Facet Biotech Corporation (NASDAQ:FACT) 79.8%
169 Indevus Pharmaceuticals (NASDAQ:IDEV) 78.3%
170 Alphatec Holdings, Inc. (NASDAQ:ATEC) 78.3%
171 RehabCare Group, Inc. (NYSE:RHB) 78.3%
172 CIGNA Corporation (NYSE:CI) 78.2%
173 Urologix, Inc. (NASDAQ:ULGX) 78.2%
174 Align Technology, Inc. (NASDAQ:ALGN) 77.6%
175 Cleveland BioLabs, Inc. (NASDAQ:CBLI) 77.5%
176 Mylan Inc. (NASDAQ:MYL) 77.5%
177 Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN) 77.0%
178 Nile Therapeutics, Inc. (NASDAQ:NLTX) 76.5%
179 Mednax, Inc. (NYSE:MD) 76.3%
180 Par Pharmaceutical Companies, Inc. (NYSE:PRX) 74.9%
181 WorldHeart Corporation (USA) (NASDAQ:WHRT) 74.8%
182 Hospira, Inc. (NYSE:HSP) 74.8%
183 Clinical Data, Inc. (NASDAQ:CLDA) 74.7%
184 Kinetic Concepts, Inc. (NYSE:KCI) 73.9%
185 Novavax, Inc. (NASDAQ:NVAX) 73.5%
186 CombinatoRx, Incorporated (NASDAQ:CRXX) 72.6%
187 Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) 69.4%
188 National Dentex Corporation (NASDAQ:NADX) 69.2%
189 Medicis Pharmaceutical Corporation (NYSE:MRX) 69.0%
190 Insmed Incorporated (NASDAQ:INSM) 69.0%
191 Allied Healthcare Product (NASDAQ:AHPI) 69.0%
192 3SBio Inc. (ADR) (NASDAQ:SSRX) 64.5%
193 Emeritus Corporation (NYSE:ESC) 63.7%
194 Solta Medical Inc. (NASDAQ:SLTM) 63.5%
195 Forbes Medi-Tech Inc. (USA) (NASDAQ:FMTI) 63.2%
196 HEALTHSOUTH Corp. (NYSE:HLS) 63.1%
197 McKesson Corporation (NYSE:MCK) 63.0%
198 Alcon, Inc. (NYSE:ACL) 62.9%
199 ImClone Systems Incorporated (NASDAQ:IMCL) 62.8%
200 Span-America Medical Systems, Inc. (NASDAQ:SPAN) 62.4%
201 Arcadia Resources, Inc. (AMEX:KAD) 62.2%
202 Odyssey HealthCare, Inc. (NASDAQ:ODSY) 62.2%
203 Affymetrix, Inc. (NASDAQ:AFFX) 61.9%
204 Generex Biotechnology Corporation (NASDAQ:GNBT) 61.3%
205 Synergetics USA Inc. (NASDAQ:SURG) 61.1%
206 Waters Corporation (NYSE:WAT) 61.1%
207 Kewaunee Scientific Corporation (NASDAQ:KEQU) 60.8%
208 Mindray Medical International Limited (NYSE:MR) 60.5%
209 Somaxon Pharmaceuticals, Inc. (NASDAQ:SOMX) 60.1%
210 Insulet Corporation (NASDAQ:PODD) 60.0%
211 Heska Corporation (NASDAQ:HSKA) 59.9%
212 OrthoLogic Corporation (NASDAQ:CAPS) 59.5%
213 Young Innovations, Inc. (NASDAQ:YDNT) 59.5%
214 Warner Chilcott Plc (NASDAQ:WCRX) 58.5%
215 STAAR Surgical Company (NASDAQ:STAA) 58.4%
216 Sangamo Biosciences, Inc. (NASDAQ:SGMO) 58.3%
217 VIVUS, Inc. (NASDAQ:VVUS) 58.3%
218 Micromet Inc. (NASDAQ:MITI) 58.3%
219 Allion Healthcare, Inc. (NASDAQ:ALLI) 58.3%
220 China-Biotics Inc. (NASDAQ:CHBT) 58.0%
221 BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) 57.0%
222 Invacare Corporation (NYSE:IVC) 56.8%
223 Nektar Therapeutics (NASDAQ:NKTR) 55.4%
224 Universal Health Services, Inc. (NYSE:UHS) 55.3%
225 Express Scripts, Inc. (NASDAQ:ESRX) 54.8%
226 DUSA Pharmaceuticals, Inc. (NASDAQ:DUSA) 54.3%
227 Virtual Radiologic Corporation (NASDAQ:VRAD) 53.7%
228 QLT Inc. (USA) (NASDAQ:QLTI) 53.1%
229 Medical Nutrition USA, Inc. (NASDAQ:MDNU) 52.8%
230 Strategic Diagnostics Inc. (NASDAQ:SDIX) 51.7%
231 Clarient, Inc. (NASDAQ:CLRT) 51.5%
232 Coventry Health Care, Inc. (NYSE:CVH) 51.5%
233 PharmAthene, Inc. (AMEX:PIP) 51.3%
234 Pro-Dex, Inc. (NASDAQ:PDEX) 51.2%
235 Biovail Corporation (USA) (NYSE:BVF) 50.7%
236 Nutraceutical Int’l Corp. (NASDAQ:NUTR) 50.5%
237 Rockwell Medical Technologies, Inc. (NASDAQ:RMTI) 50.1%
238 Dynavax Technologies Corporation (NASDAQ:DVAX) 50.0%
239 Pharmasset, Inc. (NASDAQ:VRUS) 50.0%
240 The Aristotle Corporation (NASDAQ:ARTL) 49.9%
241 Edwards Lifesciences Corp (NYSE:EW) 47.9%
242 ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) 47.8%
243 Smith & Nephew plc (ADR) (NYSE:SNN) 47.2%
244 Beckman Coulter, Inc. (NYSE:BEC) 47.0%
245 BioSphere Medical, Inc. (NASDAQ:BSMD) 46.6%
246 Nabi Biopharmaceuticals (NASDAQ:NABI) 46.3%
247 Healthways, Inc. (NASDAQ:HWAY) 46.2%
248 Continucare Corporation (AMEX:CNU) 46.0%
249 Eurand N.V. (NASDAQ:EURX) 45.8%
250 Mediware Info. Systems (NASDAQ:MEDW) 45.8%
251 Capital Senior Living Corporation (NYSE:CSU) 45.6%
252 Nymox Pharmaceutical Corporation (NASDAQ:NYMX) 45.6%
253 Allergan, Inc. (NYSE:AGN) 45.4%
254 Valeant Pharmaceuticals International (NYSE:VRX) 45.3%
255 Penwest Pharmaceuticals (NASDAQ:PPCO) 45.2%
256 Obagi Medical Products, Inc. (NASDAQ:OMPI) 44.2%
257 ChemGenex Pharmaceuticals Limited (ADR) (NASDAQ:CXSPY) 44.1%
258 BioSpecifics Technologies Corp. (NASDAQ:BSTC) 43.8%
259 Celsion Corporation (NASDAQ:CLSN) 43.6%
260 ThermoGenesis Corp. (NASDAQ:KOOL) 43.6%
261 United Therapeutics Corporation (NASDAQ:UTHR) 43.6%
262 Analogic Corporation (NASDAQ:ALOG) 43.2%
263 Crucell N.V. (ADR) (NASDAQ:CRXL) 42.7%
264 MTS Medication Technologies, Inc. (NASDAQ:MTSI) 42.5%
265 SuperGen, Inc. (NASDAQ:SUPG) 42.4%
266 Atrion Corporation (NASDAQ:ATRI) 42.2%
267 BioDelivery Sciences International, Inc. (NASDAQ:BDSI) 42.1%
268 Pressure BioSciences, Inc. (NASDAQ:PBIO) 41.9%
269 RTI Biologics Inc. (NASDAQ:RTIX) 40.9%
270 Zimmer Holdings, Inc. (NYSE:ZMH) 40.8%
271 Abaxis, Inc. (NASDAQ:ABAX) 40.7%
272 HMS Holdings Corp. (NASDAQ:HMSY) 40.7%
273 IDEXX Laboratories, Inc. (NASDAQ:IDXX) 40.6%
274 Catalyst Health Solutions, Inc. (NASDAQ:CHSI) 40.4%
275 MWI Veterinary Supply, Inc. (NASDAQ:MWIV) 40.2%
276 Inspire Pharmaceuticals, Inc. (NASDAQ:ISPH) 40.0%
277 Anadys Pharmaceuticals, Inc. (NASDAQ:ANDS) 39.7%
278 CorVel Corporation (NASDAQ:CRVL) 38.5%
279 Patterson Companies, Inc. (NASDAQ:PDCO) 38.0%
280 POZEN Inc. (NASDAQ:POZN) 37.9%
281 Harvard Bioscience, Inc. (NASDAQ:HBIO) 37.7%
282 Henry Schein, Inc. (NASDAQ:HSIC) 37.7%
283 AmerisourceBergen Corp. (NYSE:ABC) 37.4%
284 PerkinElmer, Inc. (NYSE:PKI) 36.9%
285 Tongjitang Chinese Medicines Co. (ADR) (NYSE:TCM) 34.7%
286 ResMed Inc. (NYSE:RMD) 34.1%
287 Exelixis, Inc. (NASDAQ:EXEL) 33.7%
288 ADVENTRX Pharmaceuticals, Inc. (AMEX:ANX) 33.3%
289 Steris Corporation (NYSE:STE) 33.2%
290 TomoTherapy Incorporated (NASDAQ:TOMO) 33.2%
291 Utah Medical Products, Inc. (NASDAQ:UTMD) 33.0%
292 Neogen Corporation (NASDAQ:NEOG) 33.0%
293 Watson Pharmaceuticals, Inc. (NYSE:WPI) 32.3%
294 Hill-Rom Holdings, Inc. (NYSE:HRC) 32.1%
295 MAKO Surgical Corp. (NASDAQ:MAKO) 31.7%
296 Nanosphere, Inc. (NASDAQ:NSPH) 31.5%
297 Millipore Corporation (NYSE:MIL) 31.5%
298 Lincare Holdings Inc. (NASDAQ:LNCR) 31.4%
299 Poniard Pharmaceuticals, Inc. (NASDAQ:PARD) 31.1%
300 America Service Group Inc. (NASDAQ:ASGR) 30.9%
301 Bovie Medical Corporation (AMEX:BVX) 30.6%
302 Emergency Medical Services Corporation (NYSE:EMS) 30.3%
303 Varian Medical Systems, Inc. (NYSE:VAR) 30.2%
304 LCA-Vision Inc. (NASDAQ:LCAV) 29.7%
305 ZOLL Medical Corporation (NASDAQ:ZOLL) 29.5%
306 Bio-Rad Laboratories, Inc. (NYSE:BIO) 29.5%
307 TLC Vision Corporation (USA) (NASDAQ:TLCV) 29.4%
308 PAREXEL International Corporation (NASDAQ:PRXL) 29.3%
309 iCAD, INC. (NASDAQ:ICAD) 29.2%
310 Cepheid (NASDAQ:CPHD) 28.8%
311 Novo Nordisk A/S (ADR) (NYSE:NVO) 28.7%
312 LifePoint Hospitals, Inc. (NASDAQ:LPNT) 28.7%
313 Cardinal Health, Inc. (NYSE:CAH) 28.4%
314 Biolase Technology, Inc. (NASDAQ:BLTI) 28.2%
315 Lannett Company, Inc. (AMEX:LCI) 28.0%
316 PDL BioPharma Inc. (NASDAQ:PDLI) 27.8%
317 Opko Health Inc. (AMEX:OPK) 27.8%
318 Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) 26.9%
319 Cambrex Corporation (NYSE:CBM) 26.8%
320 Medtronic, Inc. (NYSE:MDT) 26.1%
321 Response Genetics, Inc. (NASDAQ:RGDX) 26.1%
322 Shire Plc. (ADR) (NASDAQ:SHPGY) 26.0%
323 Covidien Ltd. (NYSE:COV) 26.0%
324 Home Diagnostics, Inc. (NASDAQ:HDIX) 26.0%
325 Birner Dental Mgmt. Services (NASDAQ:BDMS) 25.9%
326 Repligen Corporation (NASDAQ:RGEN) 25.9%
327 MAP Pharmaceuticals Inc. (NASDAQ:MAPP) 25.4%
328 Senomyx Inc. (NASDAQ:SNMX) 25.1%
329 American Medical Alert (NASDAQ:AMAC) 25.0%
330 MDS Inc. (USA) (NYSE:MDZ) 24.6%
331 Genetic Technologies Limited (ADR) (NASDAQ:GENE) 24.4%
332 K-V Pharmaceutical Company (NYSE:KV.A) 24.0%
333 Metabasis Therapeutics, Inc. (NASDAQ:MBRX) 23.9%
334 Teva Pharmaceutical Industries Ltd (ADR) (NASDAQ:TEVA) 23.8%
335 Charles River Laboratories (NYSE:CRL) 23.8%
336 Metropolitan Health Networks, Inc. (AMEX:MDF) 23.1%
337 Orexigen Therapeutics, Inc. (NASDAQ:OREX) 23.1%
338 Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) 22.8%
339 SonoSite, Inc. (NASDAQ:SONO) 22.6%
340 Qiagen NV (NASDAQ:QGEN) 22.5%
341 Syneron Medical Ltd. (NASDAQ:ELOS) 22.4%
342 Cantel Medical Corp. (NYSE:CMN) 22.4%
343 Stryker Corporation (NYSE:SYK) 22.0%
344 Bio-Reference Laboratories, Inc. (NASDAQ:BRLI) 21.8%
345 NovaMed, Inc. (NASDAQ:NOVA) 21.7%
346 Perrigo Company (NASDAQ:PRGO) 21.7%
347 NexMed, Inc. (NASDAQ:NEXM) 21.4%
348 Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) 20.8%
349 Enzo Biochem, Inc. (NYSE:ENZ) 20.7%
350 BioMimetic Therapeutics, Inc. (NASDAQ:BMTI) 20.4%
351 Cadence Pharmaceuticals, Inc. (NASDAQ:CADX) 20.3%
352 U.S. Physical Therapy, Inc. (NASDAQ:USPH) 20.2%
353 Kensey Nash Corporation (NASDAQ:KNSY) 20.0%
354 Mannatech, Inc. (NASDAQ:MTEX) 20.0%
355 Merck & Co., Inc. (NYSE:MRK) 19.9%
356 Medical Action Industries (NASDAQ:MDCI) 19.9%
357 Encorium Group Inc. (NASDAQ:ENCO) 19.6%
358 Geron Corporation (NASDAQ:GERN) 19.5%
359 Cytori Therapeutics Inc. (USA) (NASDAQ:CYTX) 19.4%
360 Cytokinetics, Inc. (NASDAQ:CYTK) 19.3%
361 XOMA Limited (NASDAQ:XOMA) 19.2%
362 DaVita Inc. (NYSE:DVA) 18.9%
363 Natural Alternatives International, Inc. (NASDAQ:NAII) 18.9%
364 National Health Investors (NYSE:NHI) 18.7%
365 Neurogen Corporation (NASDAQ:NRGN) 18.1%
366 Javelin Pharmaceuticals Inc. (AMEX:JAV) 17.6%
367 Sanofi-Aventis SA (ADR) (NYSE:SNY) 17.1%
368 ICON plc (ADR) (NASDAQ:ICLR) 16.8%
369 Acorda Therapeutics Inc. (NASDAQ:ACOR) 16.5%
370 DENTSPLY International Inc. (NASDAQ:XRAY) 16.4%
371 IntegraMed America, Inc. (NASDAQ:INMD) 16.3%
372 Forest Laboratories, Inc. (NYSE:FRX) 16.1%
373 Universal American Corporation (NYSE:UAM) 15.4%
374 Kindred Healthcare, Inc. (NYSE:KND) 15.1%
375 Covance Inc. (NYSE:CVD) 14.9%
376 AngioDynamics, Inc. (NASDAQ:ANGO) 14.8%
377 Uroplasty, Inc. (AMEX:UPI) 14.7%
378 Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) 14.7%
379 Genentech, Inc. (NYSE:DNA) 14.6%
380 CPEX Pharmaceuticals, Inc. (NASDAQ:CPEX) 14.4%
381 Laboratory Corp. of America Holdings (NYSE:LH) 14.4%
382 Angeion Corporation (NASDAQ:ANGN) 14.3%
383 Ardea Biosciences, Inc. (NASDAQ:RDEA) 14.3%
384 Halozyme Therapeutics, Inc. (NASDAQ:HALO) 13.8%
385 Chemed Corporation (NYSE:CHE) 13.6%
386 Theravance, Inc. (NASDAQ:THRX) 13.3%
387 Conceptus, Inc. (NASDAQ:CPTS) 13.0%
388 OraSure Technologies, Inc. (NASDAQ:OSUR) 12.8%
389 EpiCept Corporation (NASDAQ:EPCT) 12.5%
390 Fresenius Medical Care AG & Co. (ADR) (NYSE:FMS) 12.4%
391 BioClinica, Inc. (NASDAQ:BIOC) 12.3%
392 AdvanSource Biomaterials Corporation (AMEX:ASB) 12.0%
393 Quest Diagnostics Incorporated (NYSE:DGX) 12.0%
394 Theragenics Corporation (NYSE:TGX) 12.0%
395 Micrus Endovascular Corporation (NASDAQ:MEND) 11.6%
396 GlaxoSmithKline plc (ADR) (NYSE:GSK) 11.4%
397 King Pharmaceuticals, Inc. (NYSE:KG) 11.1%
398 AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) 10.9%
399 Orthovita, Inc. (NASDAQ:VITA) 10.6%
400 Ore Pharmaceutical Holdings Inc (NASDAQ:ORXE) 10.4%
401 Cynosure, Inc. (NASDAQ:CYNO) 10.2%
402 Hologic, Inc. (NASDAQ:HOLX) 10.1%
403 IVAX Diagnostics, Inc. (AMEX:IVD) 9.6%
404 Neuralstem, Inc. (AMEX:CUR) 9.3%
405 AstraZeneca plc (ADR) (NYSE:AZN) 9.2%
406 Assisted Living Concepts, Inc. (NYSE:ALC) 9.1%
407 Becton, Dickinson and Co. (NYSE:BDX) 7.8%
408 Elan Corporation, plc (ADR) (NYSE:ELN) 7.7%
409 Dyax Corp. (NASDAQ:DYAX) 7.4%
410 NightHawk Radiology Holdings, Inc. (NASDAQ:NHWK) 7.4%
411 Accuray Incorporated (NASDAQ:ARAY) 7.4%
412 Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) 7.1%
413 Animal Health International, Inc. (NASDAQ:AHII) 7.0%
414 Genoptix, Inc. (NASDAQ:GXDX) 7.0%
415 Novartis AG (ADR) (NYSE:NVS) 6.8%
416 Cyberonics, Inc. (NASDAQ:CYBX) 6.2%
417 Pet DRx Corporation (NASDAQ:VETS) 5.6%
418 Bristol Myers Squibb Co. (NYSE:BMY) 5.2%
419 PSS World Medical, Inc. (NASDAQ:PSSI) 4.6%
420 Targeted Genetics Corporation (NASDAQ:TGEN) 4.6%
421 Boston Scientific Corporation (NYSE:BSX) 4.5%
422 HealthTronics Inc. (NASDAQ:HTRN) 4.4%
423 MEDTOX Scientific, Inc. (NASDAQ:MTOX) 4.4%
424 Natus Medical, Inc. (NASDAQ:BABY) 4.3%
425 Johnson & Johnson (NYSE:JNJ) 4.2%
426 St. Jude Medical, Inc. (NYSE:STJ) 4.1%
427 Seattle Genetics, Inc. (NASDAQ:SGEN) 4.0%
428 Techne Corporation (NASDAQ:TECH) 4.0%
429 Health Care REIT, Inc. (NYSE:HCN) 3.9%
430 Owens & Minor, Inc. (NYSE:OMI) 3.7%
431 Pfizer Inc. (NYSE:PFE) 3.7%
432 West Pharmaceutical Services Inc. (NYSE:WST) 3.3%
433 Dialysis Corporation of America (NASDAQ:DCAI) 3.2%
434 Teleflex Incorporated (NYSE:TFX) 3.1%
435 Illumina, Inc. (NASDAQ:ILMN) 2.9%
436 Marshall Edwards, Inc. (NASDAQ:MSHL) 2.9%
437 ATS Medical, Inc. (NASDAQ:ATSI) 2.5%
438 Symmetry Medical Inc. (NYSE:SMA) 2.4%
439 Cutera, Inc. (NASDAQ:CUTR) 2.4%
440 Progen Pharmaceuticals Limited (USA) (NASDAQ:PGLA) 2.1%
441 InterMune, Inc. (NASDAQ:ITMN) 2.0%
442 Baxter International Inc. (NYSE:BAX) 1.4%
443 ICU Medical, Incorporated (NASDAQ:ICUI) 1.3%
444 Quidel Corporation (NASDAQ:QDEL) 1.2%
445 Emergent Group Inc (AMEX:LZR) 1.2%
446 Simcere Pharmaceutical Group (NYSE:SCR) 0.8%
447 Volcano Corporation (NASDAQ:VOLC) 0.8%
448 Allos Therapeutics, Inc. (NASDAQ:ALTH) 0.7%
449 Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) 0.5%
450 Abbott Laboratories (NYSE:ABT) 0.5%
451 Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) 0.0%
452 Celgene Corporation (NASDAQ:CELG) -0.7%
453 Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) -0.9%
454 Genomic Health, Inc. (NASDAQ:GHDX) -1.0%
455 AMN Healthcare Services, Inc. (NYSE:AHS) -1.2%
456 Molecular Insight Pharmaceuticals, Inc. (NASDAQ:MIPI) -1.6%
457 Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) -2.1%
458 NuVasive, Inc. (NASDAQ:NUVA) -2.5%
459 Biogen Idec Inc. (NASDAQ:BIIB) -2.6%
460 Gen-Probe Incorporated (NASDAQ:GPRO) -2.6%
461 Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) -2.8%
462 Grupo Casa Saba, S.A. (ADR) (NYSE:SAB) -2.8%
463 Sun Healthcare Group, Inc. (NASDAQ:SUNH) -3.5%
464 Exactech, Inc. (NASDAQ:EXAC) -4.0%
465 Amgen, Inc. (NASDAQ:AMGN) -4.1%
466 C.R. Bard, Inc. (NYSE:BCR) -4.2%
467 Merit Medical Systems, Inc. (NASDAQ:MMSI) -4.4%
468 BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) -4.7%
469 Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) -4.7%
470 DARA BioSciences, Inc. (NASDAQ:DARA) -5.0%
471 Escalon Medical Corp. (NASDAQ:ESMC) -5.0%
472 Haemonetics Corporation (NYSE:HAE) -5.2%
473 SCOLR Pharma Inc. (AMEX:DDD) -6.2%
474 China Sky One Medical, Inc. (NASDAQ:CSKI) -6.3%
475 Otix Global, Inc. (NASDAQ:OTIX) -7.0%
476 Chattem Inc. (NASDAQ:CHTT) -7.1%
477 Magellan Health Services, Inc. (NASDAQ:MGLN) -7.5%
478 Schiff Nutrition International Inc. (NYSE:WNI) -7.7%
479 Hanger Orthopedic Group, Inc. (NYSE:HGR) -8.6%
480 Centene Corporation (NYSE:CNC) -8.6%
481 Amedisys, Inc. (NASDAQ:AMED) -8.8%
482 Adolor Corporation (NASDAQ:ADLR) -9.0%
483 Daxor Corporation (AMEX:DXR) -9.1%
484 Eli Lilly & Co. (NYSE:LLY) -9.1%
485 Gilead Sciences, Inc. (NASDAQ:GILD) -9.3%
486 SurModics, Inc. (NASDAQ:SRDX) -9.3%
487 Novogen Limited (ADR) (NASDAQ:NVGN) -9.6%
488 AmSurg Corp. (NASDAQ:AMSG) -9.9%
489 Masimo Corporation (NASDAQ:MASI) -9.9%
490 Wright Medical Group, Inc. (NASDAQ:WMGI) -10.0%
491 Integra LifeSciences Holdings Corp. (NASDAQ:IART) -10.1%
492 Life Sciences Research, Inc. (NYSE:LSR) -10.3%
493 CONMED Corporation (NASDAQ:CNMD) -10.4%
494 Vascular Solutions, Inc. (NASDAQ:VASC) -10.4%
495 SRI/Surgical Express, Inc. (NASDAQ:STRC) -10.6%
496 Thoratec Corporation (NASDAQ:THOR) -10.6%
497 Psychemedics Corp. (NASDAQ:PMD) -11.0%
498 Icagen, Inc. (NASDAQ:ICGN) -11.1%
499 CAS Medical Systems, Inc. (NASDAQ:CASM) -11.9%
500 CombiMatrix Corporation (NASDAQ:CBMX) -12.3%
501 Somanetics Corporation (NASDAQ:SMTS) -12.9%
502 Stereotaxis, Inc. (NASDAQ:STXS) -13.0%
503 LHC Group, Inc. (NASDAQ:LHCG) -13.2%
504 The Ensign Group, Inc. (NASDAQ:ENSG) -13.2%
505 Cardium Therapeutics Inc. (AMEX:CXM) -13.3%
506 Biodel Inc (NASDAQ:BIOD) -13.9%
507 Hythiam Inc. (NASDAQ:HYTM) -13.9%
508 PHC, Inc. (AMEX:PHC) -14.1%
509 Endo Pharmaceuticals (NASDAQ:ENDP) -14.2%
510 Albany Molecular Research, Inc. (NASDAQ:AMRI) -14.8%
511 Res-Care, Inc. (NASDAQ:RSCR) -15.1%
512 ARYx Therapeutics, Inc. (NASDAQ:ARYX) -15.2%
513 Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) -15.8%
514 OSI Pharmaceuticals, Inc. (NASDAQ:OSIP) -16.0%
515 Omnicare, Inc. (NYSE:OCR) -16.3%
516 Gentiva Health Services, Inc. (NASDAQ:GTIV) -17.1%
517 Dynacq Healthcare, Inc. (NASDAQ:DYII) -17.1%
518 Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) -17.9%
519 CARDIOME PHARMA CORP (NASDAQ:CRME) -18.0%
520 Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) -18.1%
521 Meridian Bioscience, Inc. (NASDAQ:VIVO) -18.1%
522 Alkermes, Inc. (NASDAQ:ALKS) -18.7%
523 Vision-Sciences, Inc. (NASDAQ:VSCI) -19.0%
524 Cypress Bioscience, Inc. (NASDAQ:CYPB) -19.2%
525 Skilled Healthcare Group, Inc. (NYSE:SKH) -19.6%
526 Pain Therapeutics, Inc. (NASDAQ:PTIE) -19.8%
527 Almost Family, Inc. (NASDAQ:AFAM) -19.8%
528 StemCells, Inc. (NASDAQ:STEM) -19.9%
529 ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) -20.8%
530 IRIS International, Inc. (NASDAQ:IRIS) -21.5%
531 Landauer, Inc. (NYSE:LDR) -21.7%
532 ArQule, Inc. (NASDAQ:ARQL) -21.8%
533 Palomar Medical Technologies, Inc. (NASDAQ:PMTI) -22.0%
534 Labopharm Inc. (NASDAQ:DDSS) -22.5%
535 Cephalon, Inc. (NASDAQ:CEPH) -22.6%
536 Ligand Pharmaceuticals Inc. (NASDAQ:LGND) -23.0%
537 AMERIGROUP Corporation (NYSE:AGP) -23.3%
538 TorreyPines Therapeutics Inc. (NASDAQ:RPTP) -23.8%
539 Genzyme Corporation (NASDAQ:GENZ) -24.6%
540 Psychiatric Solutions, Inc. (NASDAQ:PSYS) -24.6%
541 BMP Sunstone Corp. (NASDAQ:BJGP) -25.0%
542 Columbia Laboratories Inc. (NASDAQ:CBRX) -25.2%
543 Myriad Genetics, Inc. (NASDAQ:MYGN) -25.3%
544 Infinity Pharmaceuticals Inc. (NASDAQ:INFI) -25.5%
545 National HealthCare Corporation (AMEX:NHC) -26.0%
546 Neurobiological Technologies, Inc. (NASDAQ:NTII) -26.2%
547 Pharmaceutical Product Development, Inc. (NASDAQ:PPDI) -27.5%
548 Hollis-Eden Pharmaceuticals Inc. (NASDAQ:HEPH) -27.9%
549 Alexza Pharmaceuticals, Inc. (NASDAQ:ALXA) -28.1%
550 Novadel Pharma Inc (AMEX:NVD) -28.1%
551 Rochester Medical Corporation (NASDAQ:ROCM) -28.4%
552 Rexahn Pharmaceuticals, Inc. (AMEX:RNN) -28.6%
553 Transcept Pharmaceuticals, Inc. (NASDAQ:TSPT) -29.1%
554 MedCath Corporation (NASDAQ:MDTH) -29.1%
555 Arrowhead Research Corporation (NASDAQ:ARWR) -29.4%
556 Immucor, Inc. (NASDAQ:BLUD) -29.4%
557 Cubist Pharmaceuticals, Inc. (NASDAQ:CBST) -29.8%
558 Akorn, Inc. (NASDAQ:AKRX) -30.0%
559 Alliance Imaging, Inc. (NYSE:AIQ) -30.1%
560 Caraco Pharmaceutical Laboratories Ltd. (AMEX:CPD) -30.7%
561 Greatbatch Inc. (NYSE:GB) -30.8%
562 GeoPharma, Inc. (NASDAQ:GORX) -31.3%
563 Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) -31.9%
564 Prestige Brands Holdings, Inc. (NYSE:PBH) -33.3%
565 Radient Pharmaceuticals Corporation (AMEX:RPC) -33.3%
566 Neurocrine Biosciences, Inc. (NASDAQ:NBIX) -33.4%
567 XenoPort, Inc. (NASDAQ:XNPT) -34.8%
568 Discovery Laboratories, Inc. (NASDAQ:DSCO) -34.8%
569 Luminex Corporation (NASDAQ:LMNX) -34.8%
570 Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) -35.5%
571 Kendle International Inc. (NASDAQ:KNDL) -36.0%
572 Synovis Life Technologies, Inc. (NASDAQ:SYNO) -36.0%
573 Maxygen, Inc. (NASDAQ:MAXY) -37.0%
574 CryoLife, Inc. (NYSE:CRY) -37.1%
575 Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) -37.1%
576 Synta Pharmaceuticals Corp. (NASDAQ:SNTA) -37.6%
577 China Medical Technologies, Inc. (ADR) (NASDAQ:CMED) -37.9%
578 RadNet Inc. (NASDAQ:RDNT) -37.9%
579 Aastrom Biosciences, Inc. (NASDAQ:ASTM) -38.0%
580 DURECT Corporation (NASDAQ:DRRX) -38.4%
581 Celldex Therapeutics, Inc. (NASDAQ:CLDX) -38.4%
582 Martek Biosciences Corp. (NASDAQ:MATK) -40.3%
583 ViroPharma Incorporated (NASDAQ:VPHM) -40.9%
584 RegeneRx Biopharmaceuticals, Inc. (AMEX:RGN) -42.4%
585 Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) -43.3%
586 Celera Corporation (NASDAQ:CRA) -43.9%
587 OccuLogix, Inc. (USA) (NASDAQ:TEAR) -44.0%
588 American Oriental Bioengineering, Inc. (NYSE:AOB) -44.5%
589 BSD Medical Corporation (NASDAQ:BSDM) -45.1%
590 Cardiovascular Systems, Inc. (NASDAQ:CSII) -45.5%
591 The Quigley Corporation (NASDAQ:QGLY) -46.3%
592 Emergent BioSolutions Inc. (NYSE:EBS) -47.2%
593 Abraxis Bioscience, Inc. (NASDAQ:ABII) -48.7%
594 The Medicines Company (NASDAQ:MDCO) -49.2%
595 Array BioPharma Inc. (NASDAQ:ARRY) -49.9%
596 NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) -50.4%
597 ABIOMED, Inc. (NASDAQ:ABMD) -50.4%
598 TranS1 Inc. (NASDAQ:TSON) -50.9%
599 Amicus Therapeutics, Inc. (NASDAQ:FOLD) -52.0%
600 Accelr8 Technology Corporation (AMEX:AXK) -53.9%
601 Uluru Inc. (AMEX:ULU) -53.9%
602 Senesco Technologies, Inc. (AMEX:SNT) -54.3%
603 MiddleBrook Pharmaceuticals, Inc. (NASDAQ:MBRK) -54.7%
604 Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR) -55.3%
605 Verenium Corporation (NASDAQ:VRNM) -59.2%
606 EnteroMedics Inc. (NASDAQ:ETRM) -59.6%
607 Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) -60.5%
608 Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX) -61.0%
609 PhotoMedex, Inc. (NASDAQ:PHMD) -61.7%
610 Hansen Medical, Inc. (NASDAQ:HNSN) -62.6%
611 ARCA biopharma, Inc. (NASDAQ:ABIO) -63.1%
612 RXi Pharmaceuticals Corporation (NASDAQ:RXII) -63.7%
613 Cardiac Science Corporation (NASDAQ:CSCX) -64.4%
614 Anesiva, Inc. (NASDAQ:ANSV) -64.5%
615 GTC Biotherapeutics, Inc. (NASDAQ:GTCB) -65.6%
616 Osiris Therapeutics, Inc. (NASDAQ:OSIR) -65.7%
617 Cardica, Inc. (NASDAQ:CRDC) -67.7%
618 Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX) -68.2%
619 American Caresource Holdings, Inc. (NASDAQ:ANCI) -70.5%
620 Quantum Group, Inc. (AMEX:QNGP) -70.6%
621 AspenBio Pharma, Inc. (NASDAQ:APPY) -73.1%
622 Cortex Pharmaceuticals (AMEX:COR) -73.1%
623 Matrixx Initiatives, Inc. (NASDAQ:MTXX) -74.4%
624 deCODE genetics, Inc. (NASDAQ:DCGN) -76.8%
625 GTx, Inc. (NASDAQ:GTXI) -79.2%
626 Cardionet Inc (NASDAQ:BEAT) -79.6%
627 Altus Pharmaceuticals Inc. (NASDAQ:ALTU) -83.1%
628 Sequenom, Inc. (NASDAQ:SQNM) -84.2%
629 La Jolla Pharmaceutical Company (NASDAQ:LJPC) -88.5%
630 Repros Therapeutics Inc. (NASDAQ:RPRX) -93.2%